Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
divestment
Pharma
Coherus sells Neulasta biosimilar to Intas for up to $558M
Coherus has scored up to $558 million for the last biosimilar in its portfolio, freeing up the company to go all.in on Loqtorzi.
Fraiser Kansteiner
Dec 3, 2024 4:16pm
Pfizer explores sale of hospital drugs unit: Reuters
Nov 12, 2024 11:09am
Sanofi moves to sell 50% stake in €16B consumer health unit
Oct 21, 2024 11:34am
Evonik plots 260 layoffs as it winds down some production ops
Oct 14, 2024 9:04am
Sanofi in talks over potential sale of consumer health business
Oct 11, 2024 10:13am
Sanofi sells rare disease med Enjaymo to Recordati for $825M
Oct 4, 2024 10:11am
